ESMO Clinical Practice Guidelines: Haematological Malignancies
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Acute lymphoblastic leukaemia, Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Hairy cell leukaemia, Peripheral T-cell lymphomas, Myelodysplastic syndromes, Waldenström's macroglobulinaemia, Multiple myeloma, Acute myeloblastic leukaemia in adult patients, Chronic lymphocytic leukaemia, Chronic myeloid leukemia, Hodgkin's lymphoma, Mantle cell lymphoma, Diffuse large B-cell lymphoma, Gastric marginal zone lymphoma of MALT type, Primary cutaneous lymphoma, newly diagnosed and relapsed Follicular lymphoma and extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.